Modern Radiotherapy for High-Risk and Very-High-Risk Prostate Adenocarcinoma.
2/5 보강
OpenAlex 토픽 ·
Prostate Cancer Diagnosis and Treatment
Prostate Cancer Treatment and Research
Advanced Radiotherapy Techniques
Modern radiotherapy for high-risk prostate cancer offers fewer treatments, selectively higher doses, elective pelvic nodal treatment, and the potential for intensification of androgen-deprivation ther
APA
James Chien-hung Shen, Yi An (2026). Modern Radiotherapy for High-Risk and Very-High-Risk Prostate Adenocarcinoma.. The Urologic clinics of North America, 53(2), 225-231. https://doi.org/10.1016/j.ucl.2026.02.005
MLA
James Chien-hung Shen, et al.. "Modern Radiotherapy for High-Risk and Very-High-Risk Prostate Adenocarcinoma.." The Urologic clinics of North America, vol. 53, no. 2, 2026, pp. 225-231.
PMID
41986018
Abstract
Modern radiotherapy for high-risk prostate cancer offers fewer treatments, selectively higher doses, elective pelvic nodal treatment, and the potential for intensification of androgen-deprivation therapy as well. There are active studies to better intensify or deintensify radiotherapy and androgen deprivation therapy based on novel genomic risk stratification tools.
MeSH Terms
Humans; Male; Prostatic Neoplasms; Adenocarcinoma; Androgen Antagonists; Risk Assessment
같은 제1저자의 인용 많은 논문 (5)
- Changes Over Time in Total Medicare Costs for Active Surveillance Versus Radiation Therapy in Prostate Cancer.
- Engineering CLL-1 CAR-NK cells via mRNA-LNP for potent antitumor activity and reversal of HLA-E-mediated resistance in acute myeloid leukemia.
- Treatment and survival outcomes for patients with follicular lymphoma and POD24: a systematic review and meta-analysis.
- Allostatic Load Predicts Immune-Related Toxicity and Survival in Melanoma Patients Receiving Immune Checkpoint Inhibitors.
- Retrospective analysis of primary extranodal unicentric Castleman disease: a systematic review.